Trials / Completed
CompletedNCT05414565
Post-Market Study of Alcon Intraocular Lenses
Clinical and Functional Performance of Acrysof IQ Vivity Versus Aspheric Monofocal IOLs
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate clinical and functional performance in real-world conditions in participants who have been implanted with Acrysof IQ Vivity (Extended Vision) IOLs compared with Alcon Aspheric Monofocal IOLs.
Detailed description
This observational study will enroll subjects who have been implanted with an Alcon aspheric monofocal or monofocal toric IOL no less than 4 months prior to study procedures. This study will be conducted in Australia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivity IOL | Commercially available extended vision IOL |
| DEVICE | Aspheric monofocal IOL | Commercially available aspheric IOL |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2024-04-15
- Completion
- 2024-04-15
- First posted
- 2022-06-10
- Last updated
- 2024-07-09
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05414565. Inclusion in this directory is not an endorsement.